LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
NXB
NextBoat Inc.
There isn't enough reported data to score NXB yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
NXB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Unavailable | |
| Strong |
NXB's revenue and balance sheet are currently strong, but its profitability is weak. There isn't enough data to rate its cash flow.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
NXB PE Valuation
NXB has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
NXB Forward outlook
There aren't enough analyst estimates for NXB to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over NXB in the latest year-over-year earnings comparison.
NXB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.36 | -820% |
| Q1 2026 | -$0.25 | -725% |
| Q4 2025 | -$0.10 | -350% |
NXB has swung to a loss: it lost $0.36 per share over the past year, after a profit the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over NXB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
NXB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $59.1M | +88% |
| Q1 2026 | $29.8M | +9.6% |
| Q4 2025 | $37.3M | +25% |
| Q3 2025 | $24M | -7.2% |
| Q2 2025 | $31.3M | +39% |
| Q1 2025 | $27.2M | +31% |
NXB's revenue is growing: $59M last quarter, up 88% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1.8% | -5.3 points |
| Q1 2026 | -9.6% | -13 points |
| Q4 2025 | -4.8% | -5 points |
| Q3 2025 | 1.3% | -3.7 points |
| Q2 2025 | 3.5% | +0.9 points |
| Q1 2025 | 3% | -0.5 points |
| Q4 2024 | 0.3% | N/A |
| Q3 2024 | 5% | N/A |
NXB has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
NXB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2.7M | -46% |
| Q1 2026 | -$23.7M | -$18.4M |
| Q4 2025 | -$407.7K | +$3.6M |
NXB and LCID do not have enough comparable growth data to identify a winner.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
NXB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2% | +480K shares |
| 1 year | +24% | +4.8M shares |
NXB has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | $826,176 |
| Q1 2025 | $591,906 |
| Q4 2024 | — |
| Q3 2024 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NXB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -15.4x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | 6.9x | High |
| Q1 2025 | 9.4x | High |
| Q4 2024 | 8.1x | High |
NXB has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
NXB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.0 | Oversold |
| Stochastic | 11.9 | Oversold |
NXB's weekly RSI is 19 (oversold) and its Stochastic is 12 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
NXB PE vs Consumer Cyclical Sector
NXB has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
NXB has stronger trend alignment. LCID is above 0 of 5 weekly averages versus NXB above 0 of 2.
NXB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.69 | 31% below |
| 20 week MA | $1.94 | 40% below |
NXB is in a downtrend: it's below all two of its weekly moving averages, and 40% below its 20-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
NXB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $2.71 | $1.17 | -57% |
NXB has the edge over LCID on returns for 2026, with the stronger performance.